Abstract
Ventilator associated pneumonia remains a cause of significant morbidity and mortality in Intensive Care patients despite advances in knowledge and technology. The presence of an endotracheal tube bypassing the normal airway barriers, oropharyngeal bacterial colonisation, patient position and repetitive micro-aspiration tip the host-pathogen relationship in favour of the pathogen and promote lung infection in a time-dependent manner. Defending the lung against microbial invasion and infection is a multiplicity of innate and adaptive immune mechanisms, which can identify and eliminate potential pathogens. These defence mechanisms include the ability to recognise pathogens through cell-surface receptors, antimicrobial peptides and proteins, pro and anti-inflammatory mediators and factors related to the coagulant state of the lung fluid. The mechanisms are characterised by their complexity, their remarkable degree of redundancy and effectiveness.
Keywords: Inspired Gases, Klebsiella pneumoniae, phagocytic cells, Cathelicidins, peptide antibiotics, Defensins
Current Respiratory Medicine Reviews
Title: Lung Defence Mechanisms and Their Potential Role in the Prevention of Ventilator Associated Pneumonia
Volume: 2 Issue: 3
Author(s): Matt Wise, Josephine Lightowler and Christopher Garrard
Affiliation:
Keywords: Inspired Gases, Klebsiella pneumoniae, phagocytic cells, Cathelicidins, peptide antibiotics, Defensins
Abstract: Ventilator associated pneumonia remains a cause of significant morbidity and mortality in Intensive Care patients despite advances in knowledge and technology. The presence of an endotracheal tube bypassing the normal airway barriers, oropharyngeal bacterial colonisation, patient position and repetitive micro-aspiration tip the host-pathogen relationship in favour of the pathogen and promote lung infection in a time-dependent manner. Defending the lung against microbial invasion and infection is a multiplicity of innate and adaptive immune mechanisms, which can identify and eliminate potential pathogens. These defence mechanisms include the ability to recognise pathogens through cell-surface receptors, antimicrobial peptides and proteins, pro and anti-inflammatory mediators and factors related to the coagulant state of the lung fluid. The mechanisms are characterised by their complexity, their remarkable degree of redundancy and effectiveness.
Export Options
About this article
Cite this article as:
Wise Matt, Lightowler Josephine and Garrard Christopher, Lung Defence Mechanisms and Their Potential Role in the Prevention of Ventilator Associated Pneumonia, Current Respiratory Medicine Reviews 2006; 2 (3) . https://dx.doi.org/10.2174/157339806778018971
DOI https://dx.doi.org/10.2174/157339806778018971 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Chronic obstructive pulmonary disease (COPD) from childhood to adulthood: from the past to the future
Chronic obstructive pulmonary disease (COPD) is one of the three leading causes of death worldwide, with a major prevalence in low- and middle-income countries, resulting in a high social and economic cost. It is a heterogeneous respiratory disease, treatable and preventable, that causes persistent and often progressive airway obstruction in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacological Inhibitors of NAD Biosynthesis as Potential An ticancer Agents
Recent Patents on Anti-Cancer Drug Discovery MicroRNA-372-3p Predicts Response of TACE Patients Treated with Doxorubicin and Enhances Chemosensitivity in Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Natural Compounds as Antagonists of Canonical Wnt/β-Catenin Signaling
Current Chemical Biology A Review on Biological Activities and Chemical Synthesis of Hydrazide Derivatives
Current Medicinal Chemistry Novel Therapeutic Approaches Targeting Vascular Endothelial Growth Factor and its Receptors in Haematological Malignancies
Current Cancer Drug Targets Inhibitors of ABL and the ABL-T315I Mutation
Current Topics in Medicinal Chemistry Patent Selections
Recent Patents on Anti-Infective Drug Discovery cGAS-STING Pathway as the Target of Immunotherapy for Lung Cancer
Current Cancer Drug Targets Microbubble-Assisted p53, RB, and p130 Gene Transfer in Combination with Radiation Therapy in Prostate Cancer
Current Gene Therapy Polyisoprenylated Cysteinyl Amide Inhibitors Deplete K-Ras and Induce Caspase-dependent Apoptosis in Lung Cancer Cells
Current Cancer Drug Targets MicroRNA Therapeutics: the Next Magic Bullet?
Mini-Reviews in Medicinal Chemistry Silicosis in Current Scenario: A Review of Literature
Current Respiratory Medicine Reviews Toxicities of Targeted Agents in Advanced Renal Cell Carcinoma
Current Clinical Pharmacology Membrane Permeable Lipophilic Cations as Mitochondrial Directing Groups
Current Topics in Medicinal Chemistry Targeting p53-MDM2 Interaction Using Small Molecule Inhibitors and the Challenges Needed to be Addressed
Current Drug Targets Cancer Stem Cells in Hematological Disorders: Current and Possible New Therapeutic Approaches
Current Pharmaceutical Biotechnology Meet Our Editor-in-Chief
Clinical Cancer Drugs Signaling Pathways Responsible for Cancer Cell Invasion as Targets for Cancer Therapy
Current Cancer Drug Targets Quercetin Promotes Cell Cycle Arrest and Apoptosis and Attenuates the Proliferation of Human Chronic Myeloid Leukemia Cell Line-K562 Through Interaction with HSPs (70 and 90), MAT2A and FOXM1
Anti-Cancer Agents in Medicinal Chemistry Photodynamic Therapy using Carbohydrate Conjugated Porphyrins
Drug Design Reviews - Online (Discontinued)